Report Detail
Global Botulinum Toxins Market Insights, Forecast to 2025
- RnM2849535 |
- 01 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.
The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.
The global Botulinum Toxins market is valued at 4550 million US$ in 2018 and will reach 10600 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Botulinum Toxins market based on company, product type, end user and key regions.
This report studies the global market size of Botulinum Toxins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Botulinum Toxins in these regions.
This research report categorizes the global Botulinum Toxins market by top players/brands, region, type and end user. This report also studies the global Botulinum Toxins market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP
Market size by Product
50U
100U
Other
Market size by End User
Medical
Cosmetic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Botulinum Toxins market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Botulinum Toxins market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Botulinum Toxins companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Botulinum Toxins submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Botulinum Toxins are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Botulinum Toxins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Botulinum Toxins Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Botulinum Toxins Market Size Growth Rate by Product
- 1.4.2 50U
- 1.4.3 100U
- 1.4.4 Other
- 1.5 Market by End User
- 1.5.1 Global Botulinum Toxins Market Size Growth Rate by End User
- 1.5.2 Medical
- 1.5.3 Cosmetic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Botulinum Toxins Market Size
- 2.1.1 Global Botulinum Toxins Revenue 2014-2025
- 2.1.2 Global Botulinum Toxins Sales 2014-2025
- 2.2 Botulinum Toxins Growth Rate by Regions
- 2.2.1 Global Botulinum Toxins Sales by Regions
- 2.2.2 Global Botulinum Toxins Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Botulinum Toxins Sales by Manufacturers
- 3.1.1 Botulinum Toxins Sales by Manufacturers
- 3.1.2 Botulinum Toxins Sales Market Share by Manufacturers
- 3.1.3 Global Botulinum Toxins Market Concentration Ratio (CR5 and HHI)
- 3.2 Botulinum Toxins Revenue by Manufacturers
- 3.2.1 Botulinum Toxins Revenue by Manufacturers (2014-2019)
- 3.2.2 Botulinum Toxins Revenue Share by Manufacturers (2014-2019)
- 3.3 Botulinum Toxins Price by Manufacturers
- 3.4 Botulinum Toxins Manufacturing Base Distribution, Product Types
- 3.4.1 Botulinum Toxins Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Botulinum Toxins Product Type
- 3.4.3 Date of International Manufacturers Enter into Botulinum Toxins Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Botulinum Toxins Sales by Product
- 4.2 Global Botulinum Toxins Revenue by Product
- 4.3 Botulinum Toxins Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Botulinum Toxins Breakdown Data by End User
6 North America
- 6.1 North America Botulinum Toxins by Countries
- 6.1.1 North America Botulinum Toxins Sales by Countries
- 6.1.2 North America Botulinum Toxins Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Botulinum Toxins by Product
- 6.3 North America Botulinum Toxins by End User
7 Europe
- 7.1 Europe Botulinum Toxins by Countries
- 7.1.1 Europe Botulinum Toxins Sales by Countries
- 7.1.2 Europe Botulinum Toxins Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Botulinum Toxins by Product
- 7.3 Europe Botulinum Toxins by End User
8 Asia Pacific
- 8.1 Asia Pacific Botulinum Toxins by Countries
- 8.1.1 Asia Pacific Botulinum Toxins Sales by Countries
- 8.1.2 Asia Pacific Botulinum Toxins Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Botulinum Toxins by Product
- 8.3 Asia Pacific Botulinum Toxins by End User
9 Central & South America
- 9.1 Central & South America Botulinum Toxins by Countries
- 9.1.1 Central & South America Botulinum Toxins Sales by Countries
- 9.1.2 Central & South America Botulinum Toxins Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Botulinum Toxins by Product
- 9.3 Central & South America Botulinum Toxins by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Botulinum Toxins by Countries
- 10.1.1 Middle East and Africa Botulinum Toxins Sales by Countries
- 10.1.2 Middle East and Africa Botulinum Toxins Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Botulinum Toxins by Product
- 10.3 Middle East and Africa Botulinum Toxins by End User
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan Botulinum Toxins Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Ipsen
- 11.2.1 Ipsen Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Ipsen Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Ipsen Botulinum Toxins Products Offered
- 11.2.5 Ipsen Recent Development
- 11.3 Merz Pharmaceuticals
- 11.3.1 Merz Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merz Pharmaceuticals Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merz Pharmaceuticals Botulinum Toxins Products Offered
- 11.3.5 Merz Pharmaceuticals Recent Development
- 11.4 Medytox
- 11.4.1 Medytox Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Medytox Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Medytox Botulinum Toxins Products Offered
- 11.4.5 Medytox Recent Development
- 11.5 US World Meds
- 11.5.1 US World Meds Company Details
- 11.5.2 Company Business Overview
- 11.5.3 US World Meds Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 US World Meds Botulinum Toxins Products Offered
- 11.5.5 US World Meds Recent Development
- 11.6 LIBP
- 11.6.1 LIBP Company Details
- 11.6.2 Company Business Overview
- 11.6.3 LIBP Botulinum Toxins Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 LIBP Botulinum Toxins Products Offered
- 11.6.5 LIBP Recent Development
12 Future Forecast
- 12.1 Botulinum Toxins Market Forecast by Regions
- 12.1.1 Global Botulinum Toxins Sales Forecast by Regions 2019-2025
- 12.1.2 Global Botulinum Toxins Revenue Forecast by Regions 2019-2025
- 12.2 Botulinum Toxins Market Forecast by Product
- 12.2.1 Global Botulinum Toxins Sales Forecast by Product 2019-2025
- 12.2.2 Global Botulinum Toxins Revenue Forecast by Product 2019-2025
- 12.3 Botulinum Toxins Market Forecast by End User
- 12.4 North America Botulinum Toxins Forecast
- 12.5 Europe Botulinum Toxins Forecast
- 12.6 Asia Pacific Botulinum Toxins Forecast
- 12.7 Central & South America Botulinum Toxins Forecast
- 12.8 Middle East and Africa Botulinum Toxins Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Botulinum Toxins Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Botulinum Toxins . Industry analysis & Market Report on Botulinum Toxins is a syndicated market report, published as Global Botulinum Toxins Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Botulinum Toxins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
